NCT00030368View on ClinicalTrials.gov

Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

February 28, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

DRUG

paclitaxel

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00030368 - Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter